Telix Pharmaceuticals Limited Increase Through New Leases Liabilities Arising From Financing Activities
Telix Pharmaceuticals Limited (TLPPF) reported Increase Through New Leases Liabilities Arising From Financing Activities of $8.28 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities · last filed 2026-02-20
AUD
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2024-12-31 | 2.78M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 3.44M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-12-31 | $8.28M 20-F · filed 2026-02-20 |
| 2024-12-31 | $1.84M 20-F · filed 2026-02-20 |